168 related articles for article (PubMed ID: 20729289)
1. Lipophilic statin use and risk of breast cancer subtypes.
Woditschka S; Habel LA; Udaltsova N; Friedman GD; Sieh W
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2479-87. PubMed ID: 20729289
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users.
Kumar AS; Benz CC; Shim V; Minami CA; Moore DH; Esserman LJ
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1028-33. PubMed ID: 18463402
[TBL] [Abstract][Full Text] [Related]
3. Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study.
Ahern TP; Pedersen L; Tarp M; Cronin-Fenton DP; Garne JP; Silliman RA; Sørensen HT; Lash TL
J Natl Cancer Inst; 2011 Oct; 103(19):1461-8. PubMed ID: 21813413
[TBL] [Abstract][Full Text] [Related]
4. Statins and breast cancer in postmenopausal women without hormone therapy.
Eaton M; Eklof J; Beal JR; Sahmoun AE
Anticancer Res; 2009 Dec; 29(12):5143-8. PubMed ID: 20044629
[TBL] [Abstract][Full Text] [Related]
5. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
[TBL] [Abstract][Full Text] [Related]
6. Association between common risk factors and molecular subtypes in breast cancer patients.
Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
Breast; 2013 Jun; 22(3):344-50. PubMed ID: 22981738
[TBL] [Abstract][Full Text] [Related]
7. Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors.
Kwan ML; Habel LA; Flick ED; Quesenberry CP; Caan B
Breast Cancer Res Treat; 2008 Jun; 109(3):573-9. PubMed ID: 17674197
[TBL] [Abstract][Full Text] [Related]
8. Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age.
McDougall JA; Malone KE; Daling JR; Cushing-Haugen KL; Porter PL; Li CI
Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1529-37. PubMed ID: 23833125
[TBL] [Abstract][Full Text] [Related]
9. Statin use and breast cancer risk in a large population-based setting.
Boudreau DM; Yu O; Miglioretti DL; Buist DS; Heckbert SR; Daling JR
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):416-21. PubMed ID: 17372235
[TBL] [Abstract][Full Text] [Related]
10. Statin Use and Breast Cancer Risk in the Nurses' Health Study.
Borgquist S; Tamimi RM; Chen WY; Garber JE; Eliassen AH; Ahern TP
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):201-6. PubMed ID: 26762806
[TBL] [Abstract][Full Text] [Related]
11. Statin use and risk of breast cancer.
Pocobelli G; Newcomb PA; Trentham-Dietz A; Titus-Ernstoff L; Hampton JM; Egan KM
Cancer; 2008 Jan; 112(1):27-33. PubMed ID: 18008366
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for triple-negative breast cancer in women under the age of 45 years.
Dolle JM; Daling JR; White E; Brinton LA; Doody DR; Porter PL; Malone KE
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1157-66. PubMed ID: 19336554
[TBL] [Abstract][Full Text] [Related]
13. Post-diagnostic statin use and its association with cancer recurrence and mortality in breast cancer patients: a systematic review and meta-analysis.
Jaiswal V; Agrawal V; Ang SP; Saleeb M; Ishak A; Hameed M; Rajak K; Kalra K; Jaiswal A
Eur Heart J Cardiovasc Pharmacother; 2023 Dec; 9(8):731-740. PubMed ID: 37562940
[TBL] [Abstract][Full Text] [Related]
14. Statin use and breast cancer: prospective results from the Women's Health Initiative.
Cauley JA; McTiernan A; Rodabough RJ; LaCroix A; Bauer DC; Margolis KL; Paskett ED; Vitolins MZ; Furberg CD; Chlebowski RT;
J Natl Cancer Inst; 2006 May; 98(10):700-7. PubMed ID: 16705124
[TBL] [Abstract][Full Text] [Related]
15. Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes.
Hosio M; Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Puistola U; Läärä E; Jukkola A; Karihtala P
Breast Cancer Res Treat; 2019 Jun; 175(3):741-748. PubMed ID: 30895533
[TBL] [Abstract][Full Text] [Related]
16. Alcohol, Physical Activity, Smoking, and Breast Cancer Subtypes in a Large, Nested Case-Control Study from the Norwegian Breast Cancer Screening Program.
Ellingjord-Dale M; Vos L; Hjerkind KV; Hjartåker A; Russnes HG; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
Cancer Epidemiol Biomarkers Prev; 2017 Dec; 26(12):1736-1744. PubMed ID: 28877889
[No Abstract] [Full Text] [Related]
17. Prospective analysis of association between statin use and breast cancer risk in the women's health initiative.
Desai P; Chlebowski R; Cauley JA; Manson JE; Wu C; Martin LW; Jay A; Bock C; Cote M; Petrucelli N; Rosenberg CA; Peters U; Agalliu I; Budrys N; Abdul-Hussein M; Lane D; Luo J; Park HL; Thomas F; Wactawski-Wende J; Simon MS
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1868-76. PubMed ID: 23975947
[TBL] [Abstract][Full Text] [Related]
18. Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study.
Harborg S; Heide-Jørgensen U; Ahern TP; Ewertz M; Cronin-Fenton D; Borgquist S
Breast Cancer Res Treat; 2020 Aug; 183(1):153-160. PubMed ID: 32572715
[TBL] [Abstract][Full Text] [Related]
19. Impact of statin use on cancer recurrence and mortality in breast cancer: A systematic review and meta-analysis.
Manthravadi S; Shrestha A; Madhusudhana S
Int J Cancer; 2016 Sep; 139(6):1281-8. PubMed ID: 27176735
[TBL] [Abstract][Full Text] [Related]
20. Statin use and risk of contralateral breast cancer: a nationwide cohort study.
Langballe R; Cronin-Fenton D; Dehlendorff C; Jensen MB; Ejlertsen B; Andersson M; Friis S; Mellemkjær L
Br J Cancer; 2018 Nov; 119(10):1297-1305. PubMed ID: 30353047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]